Latest News

Friday, February 15, 2019

Premarket Clearance Request Filed for Robotic Neurovascular Intervention

A premarket clearance request for a neurovascular intervention platform (CorPath GRX System; Corindus Vascular Robotics, Waltham, MA) has been filed with the Food and Drug Administration (FDA). Alread…

Read the full story

Thursday, February 14, 2019

Parkinson’s Foundation Hosting Conference on Use of Medical Marijuana

On March 6-7, in Denver, CO, The Parkinson’s Foundation will host its first conference focused on the use of medical marijuana as potential therapy for patients with Parkinson’s disease (P…

Read the full story

Wednesday, February 13, 2019

Pitolisant New Drug Application Granted Priority Review

Pitolisant (Harmony Biosciences; Plymouth Meeting, PA), an investigational drug being studied for the treatment of excessive daytime sleepiness and/or cataplexy in patients with narcolepsy, has been g…

Read the full story

Wednesday, February 13, 2019

New CPT Code for Electrocorticography From Responsive Neurostimulator

The American Medical Association (AMA) has issued a new Category/Current Procedural Terminology (CPT) code for electrocorticography from an implanted brain neurostimulator. The code applies to se…

Read the full story

Wednesday, February 13, 2019

Therapeutic Benefits of Exercise Being Studied in Patients With Alzheimer’s

HealthPartners Neuroscience Center (St. Paul, MN) has announced they will be conducting the first study of the Muscle2Mind exercise program for patients with Alzheimer’s dementia. The program ut…

Read the full story

Tuesday, February 12, 2019

Warnings and Advisories Issued to 17 Companies for Products Illegally Marketed as Treatment for Alzheimer’s Disease

The Food and Drug Administration (FDA) posted 12 warning letters and 5 online advisory letters issued to 17 foreign and domestic companies that illegally sell more than 58 products. Many of the produc…

Read the full story

Monday, February 11, 2019

Durable Benefit from Treating Batten’s Disease with Cerliponase Alfa

In an ongoing, open-label extension study of cerliponase alfa (Brineura; BioMarin, San Rafael, CA) for treatment of patients with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also know…

Read the full story

Monday, February 11, 2019

Embolization Device Receives FDA Approval for Expanded Indication for Small or Medium Wide-Neck Aneurysms

The Food and Drug Administration (FDA) approved an expanded indication for an embolization device (Pipeline™ Flex; Medtronic, Dublin, Ireland) for the treatment of small to medium wide-necked in…

Read the full story

Monday, February 11, 2019

Intensive Blood Pressure Lowering With Intravenous Thrombectomy for Acute Ischemic Stroke Did Not Improve Functional Outcomes

In results from the ENCHANTED trial (NCT01422616), presented at the International Stroke Conference (ISC) in Honolulu, Hawaii and published in The Lancet, patients provided intensive lowering of …

Read the full story

Friday, February 08, 2019

Study Shows That Learning Processes May Determine Severity of PTSD Symptoms

Findings from a study published in Nature Neurosciencereveal distinct patterns for how the brain and body respond when learning about danger and safety. The findings could help explain why post-t…

Read the full story

Friday, February 08, 2019

New Drug Application for Cenobamate to Treat Epilepsy Accepted

The Food and Drug Administration (FDA) has accepted the new drug application (NDA) filing for cenobamate (SK life science; Fair Lawn, NJ), an investigational antiepileptic drug for the treatment of pa…

Read the full story

Friday, February 08, 2019

Minimally Invasive Hemorrhage Evacuation With Thrombolysis for Intracranial Hemorrhage

Minimally invasive surgery with thrombolysis for intracranial evacuation (MISTIE) for stroke caused by supratentorial hemorrhage, for which open surgical evacuation has shown no benefit, has been stud…

Read the full story

Friday, February 08, 2019

Time Still Equals Brain, So Does Core Size for Patients With Large-Core Strokes

Research presented at the International Stroke Conference in Honolulu, HI, showed that poor outcomes for patients with large-core stroke treated with mechanical thrombectomy correlate with both time t…

Read the full story

Friday, February 08, 2019

Infectious Endocarditis-Related Stroke Increase Related to Opioid Epidemic

In research presented at the International Stroke Conference in Honolulu, HI and published in the journal Stroke, a correlation between increasing rates of infectious endocarditis-related stroke and i…

Read the full story

Friday, February 08, 2019

Prehospital Treatment to Lower Blood Pressure Does Not Improve Outcomes for Those With Acute Stroke

Results from the RIGHT-2 trial (ISRCTN26986053)presented at the International Stroke Conference in Honolulu, HI and published in The Lancet, showed that treatment with glyceryl trinitrate (G…

Read the full story
Load More